drugset / Trial / NCT03319823

Treating Nocturnal Hypertension and Nocturia in African American Men

NCT03319823 ↗

Phase 4 Withdrawn Cedars-Sinai Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a protocol to obtain pilot data to submit a new NIH grant on Nocturnal Hypertension and Nocturia. In the diversity supplement to Dr. Victor's current NIH grant (Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study) the results show that uncontrolled systolic hypertension is an independent determinant of nocturia in African American men. the investigators now want to pursue this correlation by designing a new NIH grant proposal to determine whether replacing short acting with long acting drugs and dosing them at bedtime rather than in the morning will: A. Lower systolic blood pressure during sleep B. Improve nocturia and result in better sleep quality

Timeline

Start
2017-10-25
Primary completion
2019-02-13
Completion
2021-02-01

Outcome

Outcome not reported

Stopped: “Due to the Pandemic, we decided to end this study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —
Subject Amlodipine Other / unclassified 10 mg —
Subject Indapamide Small molecule 0.625 mg —
Subject Telmisartan Other / unclassified 40 mg —
Subject Telmisartan Other / unclassified 80 mg —

Indications